Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $556.69 | 12 | 76.2% |
| Education | $173.68 | 3 | 23.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $279.32 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $153.99 | 2 | $0 (2024) |
| Mallinckrodt LLC | $118.73 | 1 | $0 (2017) |
| ABBVIE INC. | $78.39 | 3 | $0 (2024) |
| Genentech USA, Inc. | $59.94 | 3 | $0 (2022) |
| Horizon Therapeutics plc | $20.31 | 1 | $0 (2021) |
| Aurinia Pharma U.S., Inc. | $19.69 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $383.38 | 6 | Amgen Inc. ($250.00) |
| 2023 | $113.52 | 2 | Janssen Biotech, Inc. ($99.00) |
| 2022 | $55.01 | 3 | Genentech USA, Inc. ($40.21) |
| 2021 | $59.73 | 3 | Horizon Therapeutics plc ($20.31) |
| 2017 | $118.73 | 1 | Mallinckrodt LLC ($118.73) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: IMMUNOLOGY | ||||||
| 05/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $54.99 | General |
| Category: Immunology | ||||||
| 04/16/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $30.45 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inflammation | ||||||
| 02/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inflammation | ||||||
| 11/29/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 07/17/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Inflammation | ||||||
| 08/23/2022 | Genentech USA, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Immunology | ||||||
| 05/20/2022 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Inflammation | ||||||
| 01/11/2022 | Genentech USA, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Immunology | ||||||
| 11/09/2021 | Genentech USA, Inc. | Rituxan (Biological), Actemra | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: BioOncology/Immunology | ||||||
| 08/24/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Education | In-kind items and services | $19.69 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/04/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: KRYSTEXXA | ||||||
| 03/02/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $118.73 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 168 | 231 | $100,195 | $35,247 |
| 2022 | 2 | 102 | 156 | $33,717 | $14,516 |
| 2021 | 3 | 166 | 280 | $72,077 | $31,033 |
| 2020 | 3 | 118 | 142 | $29,204 | $14,877 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 73 | 136 | $50,320 | $19,408 | 38.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 95 | 95 | $49,875 | $15,839 | 31.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 75 | 129 | $26,621 | $12,001 | 45.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 27 | 27 | $7,096 | $2,515 | 35.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 90 | 204 | $51,300 | $21,791 | 42.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 63 | 63 | $18,413 | $8,314 | 45.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 13 | 13 | $2,364 | $928.32 | 39.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 65 | 65 | $15,795 | $8,078 | 51.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 42 | 66 | $11,286 | $5,825 | 51.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 11 | 11 | $2,123 | $972.92 | 45.8% |
About Dr. Jack Chen, DO
Dr. Jack Chen, DO is a Rheumatology healthcare provider based in Corvallis, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1821400367.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Chen, DO has received a total of $730.37 in payments from pharmaceutical and medical device companies, with $383.38 received in 2024. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($556.69).
As a Medicare-enrolled provider, Chen has provided services to 554 Medicare beneficiaries, totaling 809 services with total Medicare billing of $95,673. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Corvallis, OR
- Active Since 06/02/2014
- Last Updated 11/06/2020
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1821400367
Products in Payments
- Otezla (Drug) $264.52
- TREMFYA (Drug) $153.99
- ACTHAR (Biological) $118.73
- RINVOQ (Biological) $47.94
- Actemra (Biological) $40.21
- HUMIRA (Biological) $30.45
- KRYSTEXXA (Biological) $20.31
- Rituxan (Biological) $19.73
- LUPKYNIS (Drug) $19.69
- Enbrel (Biological) $14.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.